Medical Pharmaceutical Supply – Sodium Chloride Injection

The contract encompasses the supply of sterile, nonpyrogenic Sodium Chloride Injection intended for fluid and electrolyte replenishment, with all products required to meet United States Pharmacopeia standards and medical labeling requirements. The packaging must comply with stringent regulatory specifications to ensure safety, purity, and suitability for clinical use. This procurement is issued as a subcontract under the NAICS code 325412, targeting manufacturers or distributors capable of delivering reliable, high-quality pharmaceuticals in accordance with federal medical supply protocols. The place of performance is designated as Sea Girt, New Jersey, with a zip code of 08750-0000, indicating the operational location for fulfillment and delivery. The solicitation was posted on July 20, 2026, with a firm response deadline of July 27, 2026, placing this as a time-sensitive opportunity for qualified vendors. The contracting agency is the Department of Defense through its Medical Supply Chain Pharm FSA, signaling the product is destined for use within military or government healthcare systems. All bidders must ensure their submissions align with the requirements specified in the DIBBS portal, accessible via the provided link, and be prepared to demonstrate capacity for consistent production, quality control, and timely delivery of large-scale pharmaceutical quantities to meet critical operational needs.